The Defense Logistics Agency awarded a firm fixed-price delivery order valued at two hundred thirty-two dollars and thirty-nine cents to Amerisourcebergen Drug Corporation for the supply of ninety 150-milligram tablets of bupropion hydrochloride extended-release. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of one day from July 12 through July 13, 2023. The prime contractor, Amerisourcebergen Drug Corporation, is a division of Amerisourcebergen Corporation. No subcontractors or set-aside designations were identified. This order is likely placed against DLA's Pharmaceutical Prime Vendor contract to support the medical readiness of DOD personnel.
Generated 12/24/23, 6:05 PM